1 |
Zhu B, Wang Y, Ming J, Chen W, Zhang L. Disease burden of COPD in China: a systematic review. Int J Chron Obstruct Pulmon Dis. 2018; 13:1353-64.
doi: 10.2147/COPD.S161555
pmid: 29731623
|
2 |
Steriade AT, Johari S, Sargarovschi N, Necula D, Tudose CE, Ionita D, et al. Predictors of outcome of noninvasive ventilation in severe COPD exacerbation. BMC Pulm Med. 2019; 19(1):131.
doi: 10.1186/s12890-019-0892-9
pmid: 31319839
|
3 |
Chaouat A, Savale L, Chouaid C, Tu L, Sztrymf B, Canuet M, et al. Role for interleukin-6 in COPD-related pulmonary hypertension. Chest. 2009; 136(3):678-87.
pmid: 19349390
|
4 |
Yang Y, Li W, Wang ZM, Sun GY, Zhou P, Han XL. Clinical significance of interleukin-6 and -8 in patients with chronic periodontal disease and acute exacerbation of chronic obstructive pulmonary disease. Zhonghua Kou Qiang Yi Xue Za Zhi. 2018; 53(5):312-7.
doi: 10.3760/cma.j.issn.1002-0098.2018.05.005
pmid: 29972988
|
5 |
Zheng J, Shi Y, Xiong L, Zhang W, Li Y, Gibson PG, et al. The expression of IL-6, TNF-α, and MCP-1 in respiratory viral infection in acute exacerbations of chronic obstructive pulmonary disease. J Immunol Res. 2017; 2017:8539294.
pmid: 28352642
|
6 |
Zhou A, Zhou Z, Peng Y, Zhao Y, Duan J, Chen P. The role of CAT in evaluating the response to treatment of patients with AECOPD. Int J Chron Obstruct Pulmon Dis. 2018; 13:2849-58.
pmid: 30237709
|
7 |
Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017.Available from: http://goldcopd.org.
|
8 |
Aloushan AF, Almoaiqel FA, Alghamdi RN, Alnahari FI, Aldosari AF, Masud N, et al. Assessment of knowledge, attitude and practice regarding oxygen therapy at emergency departments in Riyadh in 2017: A cross-sectional study. World J Emerg Med. 2019; 10(2):88-93.
doi: 10.5847/wjem.j.1920-8642.2019.02.004
pmid: 30687444
|
9 |
Arumugam SK, Mudali I, Strandvik G, EI-Menyar A, AI-Hassani A, AI-Thani H. Risk factors for ventilator-associated pneumonia in trauma patients: A descriptive analysis. World J Emerg Med. 2018; 9(3):203-10.
doi: 10.5847/wjem.j.1920-8642.2018.03.007
pmid: 29796145
|
10 |
Li S, Zheng YA. Correlation between procalcitonin and APACHE II score in patients with chronic obstructive pulmonary disease. Chin J Emerg Med. 2013; 22(3):287-90.
|
11 |
Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009; 34(3):648-54.
doi: 10.1183/09031936.00102509
pmid: 19720809
|
12 |
Chhabra SK, Dash DJ. Acute exacerbations of chronic obstructive pulmonary disease: causes and impacts. Indian J Chest Dis Allied Sci. 2014; 56(2):93-104.
pmid: 25230550
|
13 |
Chen L, Deng L, Zhao H, Huang X, He X, Li X, et al. Comparison of national early warning score, rapid emergency medicine score and acute physiology and chronic health evaluation II score for predicting outcome among emergency severe patients. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017; 29(12):1092-6.
doi: 10.3760/cma.j.issn.2095-4352.2017.12.008
pmid: 29216942
|
14 |
Oh JY, Lee YS, Min KH, Hur GY, Lee SY, Kang KH, et al. Difference in systemic inflammation and predictors of acute exacerbation between smoking-associated COPD and tuberculosis-associated COPD. Int J Chron Obstruct Pulmon Dis. 2018; 13:3381-7.
doi: 10.2147/COPD.S177371
pmid: 30425468
|
15 |
Chen YW, Leung JM, Sin DD. A systematic review of diagnostic biomarkers of copd exacerbation. PLoS One. 2016; 11(7):e0158843.
doi: 10.1371/journal.pone.0158843
pmid: 27434033
|